FGF21 and obesity due to melanocortin 4 receptor deficiency: Administration of FGF21-mimetic antibody treats diabetes and obesity FGF21 by lowering blood glucose levels and enhancing insulin sensitivity in diabetic (Foltz et al., 2012; Holland et al., 2013).